Scambia G - Search Results

1

Ultrasound morphometric and cytologic preoperative assessment of inguinal lymph-node status in women with vulvar cancer: MorphoNode study.

Garganese G, Fragomeni SM, Pasciuto T, Leombroni M, Moro F, Evangelista MT, Bove S, Gentileschi S, Tagliaferri L, Paris I, Inzani F, Fanfani F, Scambia G, Testa AC. Garganese G, et al. Among authors: scambia g. Ultrasound Obstet Gynecol. 2020 Mar;55(3):401-410. doi: 10.1002/uog.20378. Ultrasound Obstet Gynecol. 2020. PMID: 31237047 Free article.

2

Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies.

Panici PB, Scambia G, Baiocchi G, Matonti G, Capelli A, Mancuso S. Panici PB, et al. Among authors: scambia g. Obstet Gynecol. 1992 Apr;79(4):498-502. Obstet Gynecol. 1992. PMID: 1553165

3

Pelvic lymphocele following radical para-aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management.

Conte M, Panici PB, Guariglia L, Scambia G, Greggi S, Mancuso S. Conte M, et al. Among authors: scambia g. Obstet Gynecol. 1990 Aug;76(2):268-71. Obstet Gynecol. 1990. PMID: 2196500

4

Preoperative ultrasound assessment of omental spread in ovarian cancer.

Conte M, Guariglia L, Benedetti Panici P, Scambia G, Matonti G, Mancuso S. Conte M, et al. Among authors: scambia g. Gynecol Obstet Invest. 1994;38(3):213-6. doi: 10.1159/000292482. Gynecol Obstet Invest. 1994. PMID: 8001879

5

p21WAF1/CIP1 protein expression in primary ovarian cancer.

Ferrandina G, Stoler A, Fagotti A, Fanfani F, Sacco R, De Pasqua A, Mancuso S, Scambia G. Ferrandina G, et al. Among authors: scambia g. Int J Oncol. 2000 Dec;17(6):1231-5. doi: 10.3892/ijo.17.6.1231. Int J Oncol. 2000. PMID: 11078810

6

The clinical usefulness of preoperative intratumoral Doppler analysis in predicting lymph node metastasis in patients with endometrial carcinoma.

Testa AC, Scambia G, Caruso A. Testa AC, et al. Among authors: scambia g. Gynecol Oncol. 2000 Dec;79(3):522-3. doi: 10.1006/gyno.2000.6008. Gynecol Oncol. 2000. PMID: 11104634 No abstract available.

7

[Biological factors with prognostic significance in ovarian cancer].

Ferrandina G, Legge F, Fagotti A, Fanfani F, Mancuso S, Scambia G. Ferrandina G, et al. Among authors: scambia g. Minerva Ginecol. 2001 Feb;53(1 Suppl 1):40-5. Minerva Ginecol. 2001. PMID: 11526718 Review. Italian. No abstract available.

8

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.

Ferrandina G, Ranelletti FO, Lauriola L, Fanfani F, Legge F, Mottolese M, Nicotra MR, Natali PG, Zakut VH, Scambia G. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2002 May;85(2):305-10. doi: 10.1006/gyno.2002.6620. Gynecol Oncol. 2002. PMID: 11972392

9

Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy.

Testa AC, Ciampelli M, Mastromarino C, Lopez R, Zannoni GF, Mancuso S, Scambia G. Testa AC, et al. Among authors: scambia g. Ultrasound Obstet Gynecol. 2002 May;19(5):490-5. doi: 10.1046/j.1469-0705.2002.00693.x. Ultrasound Obstet Gynecol. 2002. PMID: 11982984 Free article.

10

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

Ferrandina G, Lauriola L, Zannoni GF, Fagotti A, Fanfani F, Legge F, Maggiano N, Gessi M, Mancuso S, Ranelletti FO, Scambia G. Ferrandina G, et al. Among authors: scambia g. Ann Oncol. 2002 Aug;13(8):1205-11. doi: 10.1093/annonc/mdf207. Ann Oncol. 2002. PMID: 12181243 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,091 results

Search Page

Filters